Pediatric portal hypertension: A review for primary care.
Clarissa Barbon Vogel
PMID 28406835WHAT IT FOUND
Nurse practitioners should recognize splenomegaly and upper GI bleeding as signs of pediatric portal hypertension, order Doppler ultrasound, and coordinate care with specialists.
Variceal bleeding carries 30% mortality and requires immediate emergency department referral.
Key findings
01The most common cause of pediatric portal hypertension is extrahepatic portal vein obstruction, and nurse practitioners play a role in initial recognition and health maintenance.
02Upper gastrointestinal bleeding and splenomegaly are the two most common clinical manifestations that may prompt referral, and variceal bleeding carries a 30% mortality rate.
03Doppler ultrasonography is the most useful diagnostic tool for differential diagnosis, with sensitivity and specificity above 95% for diagnosing extrahepatic portal vein obstruction.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review without a systematic search strategy, so it reflects the authors' selection of literature rather than all available evidence. Pediatric management recommendations are largely extrapolated from adult studies and expert opinion due to a lack of high-quality pediatric trials. The review focuses on noncirrhotic portal hypertension, so it does not address the more common cirrhotic causes of the condition.
Declared interests
No funding or conflict of interest declarations are provided in the supplied text.
The easy way to misread this
Do not treat the diagnostic and management steps as evidence-based protocols for pediatric portal hypertension. The review explicitly states that pediatric practices rely on expert opinion, low-quality studies, and extrapolation from adult data, meaning there is no high-certainty evidence supporting these specific clinical pathways.